Skip to main content
. Author manuscript; available in PMC: 2022 Aug 13.
Published in final edited form as: ACS Infect Dis. 2021 Jun 11;7(8):2413–2424. doi: 10.1021/acsinfecdis.1c00158

Table 3.

Activities Against E. coli in the Presence of Acquired Resistance Determinants (MIC, μg/mL)a

Resistance det WT-parental AAC(3)-II AAC(3’)-IV APH(3’)-I APH(3’)-II AAC(6’)
Strain AG001 AG003 AG173 AG163 AG166 AG175
Propylamycin 1 1 2 2 >128 1–2 2–4
Paromomycin 2 2–4 4 8–16 >128 >128 4
Lividomycin B 3 4–8 8 8–16 >128 8 8
8 2 4–8 4 16 2–4 4–8
9 2–4 2–4 4 4–8 4 4
10 2–4 4–8 8–16 16–32 4 4–8
11 1 2 4–8 4–8 2 2–4
12 4 4–8 32 32 16–32 4–8
13 2–4 4–8 8 8–16 4 4–8
14 1–2 4 4–8 >128 4 4
15 4 8 4 >32 16 8–16
a)

All values were determined in duplicate using twofold dilution series.